There were no pre-treatment differences between the OXT and PLC group regarding demographics, autism-spectrum quotient (AQ), attachment to stimulus, sex (see Table 1), or neuropsychological performance (see Supplemental Table 1). The gene discussed is OXT; the disease is autism.